OtherBASIC SCIENCE INVESTIGATIONS
Reproducibility of 18F-FDG microPET Studies in Mouse Tumor Xenografts
Mangal Dandekar, Jeffrey R. Tseng and Sanjiv S. Gambhir
Journal of Nuclear Medicine April 2007, 48 (4) 602-607; DOI: https://doi.org/10.2967/jnumed.106.036608
Mangal Dandekar
Jeffrey R. Tseng
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 48, Issue 4
April 2007
Reproducibility of 18F-FDG microPET Studies in Mouse Tumor Xenografts
Mangal Dandekar, Jeffrey R. Tseng, Sanjiv S. Gambhir
Journal of Nuclear Medicine Apr 2007, 48 (4) 602-607; DOI: 10.2967/jnumed.106.036608
Jump to section
Related Articles
Cited By...
- Plcg2M28L interacts with high fat-high sugar diet to accelerate Alzheimers disease-relevant phenotypes in mice
- The 677C>T variant in methylenetetrahydrofolate reductase causes morphological and functional cerebrovascular deficits in mice
- Cabozantinib Exhibits Potent Antitumor Activity in Colorectal Cancer Patient-Derived Tumor Xenograft Models via Autophagy and Signaling Mechanisms
- Assessment of Tryptophan Uptake and Kinetics Using 1-(2-18F-Fluoroethyl)-L-Tryptophan and {alpha}-11C-Methyl-L-Tryptophan PET Imaging in Mice Implanted with Patient-Derived Brain Tumor Xenografts
- [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity
- The Reverse Warburg Effect and 18F-FDG Uptake in Non-Small Cell Lung Cancer A549 in Mice: A Pilot Study
- 18F-FDG-PET/CT Imaging of Drug-Induced Metabolic Changes in Genetically Engineered Mouse Lung Cancer Models
- 18F-FAZA PET Imaging Response Tracks the Reoxygenation of Tumors in Mice upon Treatment with the Mitochondrial Complex I Inhibitor BAY 87-2243
- 18F-Alfatide II and 18F-FDG Dual-Tracer Dynamic PET for Parametric, Early Prediction of Tumor Response to Therapy
- Optical Metabolic Imaging Identifies Glycolytic Levels, Subtypes, and Early-Treatment Response in Breast Cancer
- Discovery and validation of small-molecule heat-shock protein 90 inhibitors through multimodality molecular imaging in living subjects
- PET of HER2-Positive Pulmonary Metastases with 18F-ZHER2:342 Affibody in a Murine Model of Breast Cancer: Comparison with 18F-FDG
- 18FDG-PET Predicts Pharmacodynamic Response to OSI-906, a Dual IGF-1R/IR Inhibitor, in Preclinical Mouse Models of Lung Cancer
- 18F-FDG Small-Animal PET/CT Differentiates Trastuzumab-Responsive from Unresponsive Human Breast Cancer Xenografts in Athymic Mice
- Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer
- Impact of Contamination from Scattered Photons in Singles-Mode Transmission Data on Quantitative Small-Animal PET Imaging
- Preclinical Efficacy of the c-Met Inhibitor CE-355621 in a U87 MG Mouse Xenograft Model Evaluated by 18F-FDG Small-Animal PET